Literature DB >> 2447779

Juxtapapillary choroidal neovascularization in older patients.

J C Kies1, A C Bird.   

Abstract

We studied retrospectively 55 eyes with juxtapapillary choroidal neovascularization in 42 patients over the age of 50 years. In all but four lesions, the choroidal neovascularization was undetected, causing the choroidal new vessel complexes to be ill defined, discontinuous, and show irregular dye leakage on fluorescein angiography. Growth of the lesion was unpredictable. Visual loss occurred in eight of 16 eyes during the first six months of follow-up. Recurrent neovascularization after photocoagulation originated in some patients from outside the pretreatment subretinal complex. Of the 15 patients with bilateral involvement, 13 had juxtapapillary lesions. Fellow eyes in patients with unilateral juxtapapillary lesions showed no predisposing abnormality at or near the nerve head. The prevalence, density, and fluorescein angiographic characteristics of drusen were different from those in age- and sex-matched patients with macular neovascularization.

Entities:  

Mesh:

Year:  1988        PMID: 2447779     DOI: 10.1016/0002-9394(88)90114-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  Susanne Binder
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

2.  Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Gaspare Monaco; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

3.  Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures.

Authors:  C M Wood; J Richardson
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

4.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  S Aisenbrey; F Gelisken; P Szurman; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

Review 5.  Treating peripapillary choroidal neovascular membranes: a review of the evidence.

Authors:  G Jutley; G Jutley; V Tah; D Lindfield; G Menon
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

6.  Central serous papillopathy by optic nerve head drusen.

Authors:  Ana Marina Suelves; Ester Francés-Muñoz; Roberto Gallego-Pinazo; Diamar Pardo-Lopez; Jose Luis Mullor; Jose Fernando Arevalo; Manuel Díaz-Llopis
Journal:  Clin Ophthalmol       Date:  2010-11-25

7.  Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes.

Authors:  Sean D Adrean; Scott Grant; Siyang Chaili
Journal:  J Ophthalmol       Date:  2017-03-26       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.